Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Py

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 10, 2023
Interstitial brachytherapy for lip carcinomas: Comparison between Ir-192 low-dose-rate and high-dose-rate treatmentM Cuenin, J Salleron, D Peiffert, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 23, 2021
Long-term outcome of Stereotactic Body Radiation Therapy for patient with unresectable liver metastases from colorectal cancerJ F Py, J Salleron, F Courrech, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 12, 2016
[Conformal radiotherapy for vertebral bone metastasis]J C Faivre, J F Py, G Vogin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 14, 2023
Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?J F Py, J Salleron, G Vogin, et al.
Brachytherapy|June 21, 2025
Transition from pulsed dose rate to high dose rate brachytherapy: Experience of a single centreS Renard, E Meknaci, C Cuisinier, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 10, 2023
Interstitial brachytherapy for lip carcinomas: Comparison between Ir-192 low-dose-rate and high-dose-rate treatmentM Cuenin, J Salleron, D Peiffert, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 23, 2021
Long-term outcome of Stereotactic Body Radiation Therapy for patient with unresectable liver metastases from colorectal cancerJ F Py, J Salleron, F Courrech, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 12, 2016
[Conformal radiotherapy for vertebral bone metastasis]J C Faivre, J F Py, G Vogin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 14, 2023
Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?J F Py, J Salleron, G Vogin, et al.
Brachytherapy|June 21, 2025
Transition from pulsed dose rate to high dose rate brachytherapy: Experience of a single centreS Renard, E Meknaci, C Cuisinier, et al.
Pageof 1